Navigation Links
Aware Announces Q1 2008 Earnings Conference Call
Date:4/23/2008

BEDFORD, Mass., April 23 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, has scheduled a conference call to discuss the company's operating results for the first quarter of 2008 on Thursday, May 8, 2008, at 5:00 p.m. Eastern Time. CEO Michael Tzannes and CFO Rick Moberg will host the earnings conference call.

This call is being webcast by Thomson and can be accessed on the Investor Relations page of our website at http://www.aware.com/ir. The conference call may also be heard by calling 617-213-4852 at least 10 minutes prior to the call start time. Please reference the confirmation number 86740432. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PHP6EQ9Y7. Pre-registering is not mandatory but is recommended as it will provide participants with a pin number to use for quick access into the live conference call.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

About Aware

Aware is a leading technology supplier for the telecommunications industries. For more than ten years, Aware has pioneered innovations at telecommunications standards-setting organizations and continues to develop and market DSL silicon intellectual property and test and diagnostics products. Its StratiPHY(TM) IP product line supports DSL standards, including ADSL2+ and VDSL2
'/>"/>

SOURCE Aware, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology news :

1. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
2. Tiny fish can yield big clues to Delaware River health
3. Men unaware of their cancer risk when female relatives test positive for BRCA mutation
4. Aware, Inc. Announces Richard Moberg to Return as CFO
5. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
6. Despite awareness of global warming Americans concerned more about local environment
7. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
8. LaserCard Corporation Announces Expansion of Middle East Project
9. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
10. Balzan Foundation announces 2007 winners
11. The American Society of Plant Biologists announces 2007 awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...d to secondhand cigarette smoke have an increased ...if they never smoked. , Results of this study a... Prevention , a journal of the American Associatio...o focus in the December issue. , This year alon...ith lung cancer; more than 159,000 will die from i...
(Date:12/2/2009)...oke their first cigarette within minutes after wak...roduct of nicotine when processed by the body, tha...r of cigarettes smoked. , "Since cotinine lev... results suggest that smokers who smoke immediatel...cancer," said researcher Joshua E. Muscat, Ph.D., ...
(Date:12/2/2009)...Smoky Mountain forest,s woodland herb population h...t understories recover from logging, according to ...ing in portions of the forest nearly 80 years ago,...ary forest floor was similar to that of undisturbe...ssor of forestry and natural resources, said that ...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Increased nicotine levels detected in those who light-up earlier 2Study finds logging effects vary based on a forest's history, climate 2Diplomat Specialty Pharmacy Continues to Expand Opens Location in Southern California 6345 1Diplomat Specialty Pharmacy Continues to Expand Opens Location in Southern California 6345 2Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 1Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 2Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 3Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 4Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety 6341 5Guided Care receives Award for Innovation in Practice Improvement 61538 1Guided Care receives Award for Innovation in Practice Improvement 61538 2
...their surprise that a drug commonly used to treat ...owth of new blood vessels commonly seen in cancers...for human use, which may fast-track its availabili... to have excess blood vessel growth, treatment wit...ercent compared to placebo. “We were surprised, to...
...vel have on the activation of the female brain? Us...aude Dreher, a researcher at the Cognitive Neurosc...ation with an American team from the National Inst...ed by Karen Berman, has identified, for the first ...eward-related functions modulated by female gonada...
...ave deduced how bony fishes conquered the oceans b...ng their eggs with the water of life ?the degradat...nes causes the eggs to fill with vital water and f...t marine teleosts that showed an unprecedented rad...ene Periods. The work is a unique hypothesis that ...
Other Biology News:Anti-fungal drug stops blood vessel growth 2The influence of the menstrual cycle on the female brain 2The influence of the menstrual cycle on the female brain 3The influence of the menstrual cycle on the female brain 4How fish conquered the ocean 2How fish conquered the ocean 3
(Date:12/2/2009)...lands, December 2 Pepscan Holding ...cusing on protein mimicking,technology for the gen...t it,has appointed Wim E.M. Mol, Ph.D. as new Chie...sponsible for all of Pepscans corporate functions ... of the company. He brings to,Pepscan more than 20...
(Date:12/2/2009)...ael, December 2 Gamida Cell announ...inical (animal study) safety and,efficacy of a gen...eill,Cornell Medical College and Gamida Cell. The ...ias such as Cooley,s Anemia. , Gamida Cel..., ex vivo,populations of stem/progenitor cells. T...
(Date:12/2/2009)...2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, In...n Board: EMDY), a leading,producer and distributor...,soybean products in China, today announced that t... US Food & Drink Executive, a quarterly magazi... the food and beverage industry. , The ar...
(Date:12/2/2009)...wswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ:...armaceutical company focused on endocrine therapy ...nd Drug Administration (FDA) has granted Fast Trac...nhibitor compound, perifosine (KRX-0401), for the ... Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX),...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...tists has performed the ultimate miniaturisation o...nucleus of an atom. This breakthrough is a key ste...e based on the fundamental theory of quantum mecha...ent technology. , In the quantum world, objects su...s simultane-ously -- that is, they could literally...
...e to $245 Million to $247 Million -, Third Quarte...million; up 73.7% from the third quarter of 2007 ...on; up 62.3% from the third quarter of 2007, ... the third quarter of 2007, -- Gross margin of ...07, -- GAAP loss per share for the quarter was ...
...mCor Systems, Inc., a,medical device company devel...M), announced today that it has signed an agreemen...ommercialize StemCor,s proprietary System,for the ...om.com/cgi-bin/prnh/20071030/STEMCORSYSTEMSLOGO ),... Hospira will manage,the clinical trial program, l...
Other Biology Technology:Memoirs of a qubit: Hybrid memory solves key problem for quantum computing 2Nuvasive Reports Third Quarter 2008 Financial Results 2Nuvasive Reports Third Quarter 2008 Financial Results 3Nuvasive Reports Third Quarter 2008 Financial Results 4Nuvasive Reports Third Quarter 2008 Financial Results 5Nuvasive Reports Third Quarter 2008 Financial Results 6Nuvasive Reports Third Quarter 2008 Financial Results 7Nuvasive Reports Third Quarter 2008 Financial Results 8Nuvasive Reports Third Quarter 2008 Financial Results 9Nuvasive Reports Third Quarter 2008 Financial Results 10Nuvasive Reports Third Quarter 2008 Financial Results 11Nuvasive Reports Third Quarter 2008 Financial Results 12StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists 2StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists 3
...olecule of fascination, being the prime precursor ...such as ACTH, -Lipotrophin (-LPH), -endorphin, Alp.... It is also a very well-conserved molecule, being...e "living fossils", the lungfish. The IDS POMC ELI...
Mouse Anti-Rat Pan-NMDA NR1 Monoclonal Antibody, Unconjugated, Clone R1JHL from Calbiochem
BRASMC (B950-05) from European Collection of Cell Cultures (ECACC)
T4 DNA Ligase from Promega
Biology Products: